JOINT FILING AGREEMENTJoint Filing Agreement • July 24th, 2006 • ConPharm • Biological products, (no disgnostic substances)
The undersigned hereby agree that (1) the Statement on Schedule 13D, dated July 24, 2006 ("Schedule 13D"), with respect to the Common Shares of Lorus Therapeutics Inc. is, and any subsequent amendment to the Schedule 13D executed by us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and (2) this agreement shall be included as an exhibit to the Schedule 13D and each such amendment thereto. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
EXHIBIT 2 SHARE PURCHASE AGREEMENT dated as of July 13, 2006Share Purchase Agreement • July 24th, 2006 • ConPharm • Biological products, (no disgnostic substances) • Ontario
andRegistration Rights Agreement • August 31st, 2006 • ConPharm • Biological products, (no disgnostic substances) • Ontario
SHARE PURCHASE WARRANT INDENTURE LORUS THERAPEUTICS INC. — AND — COMPUTERSHARE TRUST COMPANY OF CANADA Providing for the issue of up to 27,206,826 Common Share Purchase Warrants June 27, 2008Share Purchase Warrant Indenture • August 8th, 2008 • ConPharm • Biological products, (no disgnostic substances) • Ontario
NOW THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt and sufficiency whereof is hereby acknowledged, the Company hereby appoints the Warrant Agent as trustee, for the Warrantholders, to hold all rights, interests and benefits contained herein for and on behalf of those persons who become holders of Warrants from time to time issued pursuant to this Indenture and the parties hereto agree as follows:
SHARE PURCHASE AGREEMENT BETWEEN 6707157 CANADA INC. AND PINNACLE INTERNATIONAL LANDS, INC. AND HIGH TECH BETEILIGUNGEN GMBH & CO. KG MADE AS OF May 1, 2007 McCarthy Tétrault LLPShare Purchase Agreement • May 4th, 2007 • ConPharm • Biological products, (no disgnostic substances) • Ontario
HIGH TECH BETEILIGUNGEN GMBH & CO. KG, a German limited partnership, herein represented by CONPHARM ANSTALT, a Liechtenstein corporation (the “Vendor”),
